🇺🇸 FDA
Patent

US 9731002

HIV-1 GP 120 V1/V2 antigens and immunological uses thereof

granted A61KA61K39/12A61K39/21

Quick answer

US patent 9731002 (HIV-1 GP 120 V1/V2 antigens and immunological uses thereof) held by The Regents of the University of California expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K39/12, A61K39/21, A61P, A61P31/18